TRMK
Trustmark Corporation
NasdaqGSUSDEQUITY
Financial Services
DELAYED
Last price
46.52
▼ 0.06 (0.13%)
MARKET · —
Price
Open
46.58
Prev close
46.58
Day high
47.10
Day low
46.08
Volume
267.29K
Market cap
$2.71B
P/E (TTM)
11.84
52W range
36.33 – 49.00
Trailing performance
Returnvs SPY
1W
-3.67%
-2.3%
1M
+0.87%
-2.9%
3M
+4.63%
+1.5%
6M
+4.03%
-7.0%
YTD
+19.44%
+7.1%
1Y
+20.80%
+0.8%
3Y
+94.08%
+19.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$2.71B
Enterprise value$2.82B
Revenue (TTM)$815.20M
Gross profit$815.20M
EBITDA—
Net income$234.30M
EPS (TTM)$3.93
Free cash flow—
Total cash$683.71M
Total debt$797.37M
Book value / share$36.82
Shares outstanding58.23M
Float56.62M
Short % of float7.42%
Dividend yield2.15%
Beta (5Y)0.64
Valuation & profitability ratios
Trailing P/E11.84
Forward P/E11.32
PEG ratio2.29
Price / sales—
Price / book1.26
EV / revenue3.45
EV / EBITDA—
Gross margin0.00%
Operating margin36.78%
Profit margin28.74%
Return on equity11.12%
Return on assets1.24%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $810.83M | $753.11M | $773.30M | $712.20M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $224.13M | $223.01M | $165.49M | $71.89M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $224.13M | $223.01M | $165.49M | $71.89M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.96 | 1.08 | +12.3% |
| Mar 2026 | 0.88 | 0.95 | +8.2% |
| Dec 2025 | 0.91 | 0.97 | +6.4% |
| Sep 2025 | 0.93 | 0.94 | +0.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.99 | 6 | $214.53M | +4.6% |
| Next quarter | 1.00 | 6 | $216.53M | +4.6% |
| Current year | 3.94 | 6 | $848.05M | +4.6% |
| Next year | 4.11 | 6 | $886.65M | +4.6% |
Analyst targets & ownership
Mean target$49.25
High target$54.25
Low target$47.00
Implied upside5.87%
Analyst count5
ConsensusNONE
Strong buy / Buy0 / 1
Hold5
Sell / Strong sell0 / 0
Held by insiders6.81%
Held by institutions82.32%
Institutions holding392
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 28, 26 | TATE GRANVILLE JR. Officer |
STOCK | 1.61K | $0 | Direct |
| Jul 28, 26 | CHAMBERS GEORGE T. JR. Officer |
STOCK | 1.00K | $0 | Direct |
| Jul 28, 26 | HARVEY ROBERT BARRY Officer |
STOCK | 2.14K | $0 | Direct |
| May 1, 26 | DAY MONICA A Officer |
STOCK | 2.79K | $0 | Direct |
| May 1, 26 | BOND JOSEPH E. Officer and Treasurer |
STOCK | 4.47K | $0 | Direct |
| May 1, 26 | OWENS THOMAS C. Officer |
STOCK | 3.35K | $0 | Direct |
| Apr 28, 26 | COLLINS AUGUSTUS L. Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | HAYS JAMES CLAY JR Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | EDUARDO MARCELO L Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | TURNIPSEED LEA B. Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | CONERLY TRACY T Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | PUCKETT RICHARD H Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | BAKER ADOLPHUS B Director |
STOCK | 1.40K | $0 | Direct |
| Apr 28, 26 | MORRISSETTE HARRIS V Director |
STOCK | 1.40K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAKER ADOLPHUS B |
Director | 59.41K | Stock Award(Grant) |
DAY MONICA A |
Officer | 50.87K | Stock Award(Grant) |
DEWEY DUANE A |
Chief Executive Officer | 167.62K | Stock Award(Grant) |
HARVEY ROBERT BARRY |
Officer | 70.18K | Stock Award(Grant) |
HOST GERARD R |
Director | 158.20K | Stock Award(Grant) |
MORRISSETTE HARRIS V |
Director | 37.38K | Stock Award(Grant) |
OWENS THOMAS C. |
Officer | 59.60K | Stock Award(Grant) |
PUCKETT RICHARD H |
Director | 231.27K | Stock Award(Grant) |
STEVENS WAYNE ART |
Officer | 72.17K | Stock Award(Grant) |
TATE GRANVILLE JR. |
Officer | 62.96K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
47.53
-2.12% from price
SMA 20
47.53
-2.13% from price
SMA 50
46.65
-0.29% from price
SMA 100
45.45
+2.35% from price
SMA 200
43.22
+7.64% from price
EMA 12
47.32
-1.69% from price
EMA 26
47.19
-1.43% from price
EMA 50
46.63
-0.23% from price
RSI (14)
43.0
Neutral
MACD (12,26,9)
0.13
Hist -0.23
ATR (14)
0.75
1.61% of price
Realised vol 30D
15.2%
Annualised
Bollinger upper
48.93
20, 2σ
Bollinger lower
46.14
20, 2σ
50 / 200 cross
Golden
46.65 vs 43.22
Trend bias
Above 200
+7.64%
Risk profile
Beta vs SPY
0.65
Less volatile than market
Correlation to SPY
0.37
Loosely linked
Realised vol 30D
15.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.7%
Peak to trough
Max drawdown 5Y
-49.6%
Peak to trough
ATR 14
0.75
1.61% of price
Beta (reported)
0.64
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
45.00
-3.3% from spot
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
45.00
3 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
3 Small-Cap Stocks with Open Questions
StockStory · 24h ago
3 Inflated Stocks Walking a Fine Line
StockStory · 3d ago
3 Cash-Heavy Stocks We Keep Off Our Radar
StockStory · 6d ago
Trustmark (TRMK): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 13d ago
Trustmark (TRMK) On Earnings Beats And Buybacks With Valuation Questions Still Open
Simply Wall St. · 20d ago
TRMK Q2 Deep Dive: Loan Growth, Deposit Expansion, and Core System Upgrade Shape Outlook
StockStory · 23d ago
Trustmark Corp (TRMK) Q2 2026 Earnings Call Highlights: Strong Financial Performance Amid ...
GuruFocus.com · 24d ago
Trustmark Q2 Earnings Call Highlights
MarketBeat · 24d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.